Dr. Mehran Moussavian, DO

Dr. Moussavian practices at Ampla Health North Plumas Medical in Yuba City, California.

Dr. Moussavian's NPI, 1689788234, was assigned on August 19, 2006. Dr. Moussavian graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 1994. Dr. Moussavian holds California license 20A7241.

Dr. Moussavian's primary practice is Ampla Health North Plumas Medical, at 1231 Plumas St, Yuba City, CA 95991 in Sutter County. The practice phone is (530) 674-4261.

Dr. Moussavian's primary practice is Ampla Health North Plumas Medical in Yuba City, California. Dr. Moussavian is also affiliated with Oroville Hospital. The medical group on file is Ampla Health Oroville Medical & Dental. Dmand AI also links Dr. Moussavian to 3 more hospitals, 10 medical groups, 9 group practices and clinics, 1 behavioral health center and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moussavian practices, 16 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Moussavian's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Moussavian is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Moussavian is licensed in California.

Dmand AI lists aneurysm, angioplasty, aortic atherosclerois, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic embolism thrombosis and chronic hypertension among the conditions Dr. Moussavian treats.

CMS data shows 15,222 Medicare services from Dr. Moussavian across 33 procedure codes in 2024, for 3,397 Medicare patients. Medicare paid $3,362,009 for them. Every service was in an office.

CMS counts 3,397 Medicare patients who saw Dr. Moussavian in 2024. The largest group is 65 to 74, with 1,741 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 71% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moussavian's median patient age at 62, with 58% women.

In 2024, Dr. Moussavian wrote 4,067 Medicare Part D claims for 1,077 patients. 85% of them were for generic drugs. CMS names the drug for 3,838 of them, across 42 drugs with 11 or more claims each, at $607,378 in total drug cost. In 2023, CMS named 3,839 claims across 38 drugs.

Dr. Moussavian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moussavian as offering telehealth. CMS counts 1,483 procedures of varicose vein removal by Dr. Moussavian, more than 99% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Moussavian in 2003. The most frequent topics are Coronary Restenosis and Stents. Dr. Moussavian's most frequent co-authors are Paul S. Teirstein, MD, Prabhtej Singh Brara, MD and George D. Dangas, MD.

Dmand AI links Dr. Moussavian to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Atrial Fibrillation and Hemorrhage.

CMS Open Payments shows 1,858 general payments to Dr. Moussavian from 75 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 59% of the total. Janssen Pharmaceuticals, Inc paid the most, $204,423.

Dmand AI lists 1 award for Dr. Moussavian.

Dr. Moussavian graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 1994. Dr. Moussavian is a member of ACC and AOA.

Dr. Moussavian is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.